Smi Drug Discovery Limited (11175710) is a private limited with share capital incorporated on 29/01/2018 (8 years old) and registered in cambridge, CB259HA. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Smi\u2019s automated, high resolution optical technology is capable of viewing single-molecule interactions in real time. it is the first optical technology to achieve such a high spatial (1.6 nm) and temporal (500 \u00b5s) resolution. using this significant advancement in optical technology, smi is...
Change Account Reference Date Company Previous Shortened
Category:Accounts
Date:18-01-2022
Change Person Director Company With Change Date
Category:Officers
Date:17-01-2022
Change Person Director Company With Change Date
Category:Officers
Date:17-01-2022
Change Person Director Company With Change Date
Category:Officers
Date:17-01-2022
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:13-01-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:06-10-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:06-10-2021
Capital Allotment Shares
Category:Capital
Date:30-09-2021
Memorandum Articles
Category:Incorporation
Date:16-09-2021
Resolution
Category:Resolution
Date:13-09-2021
Capital Name Of Class Of Shares
Category:Capital
Date:13-09-2021
Capital Alter Shares Subdivision
Category:Capital
Date:09-09-2021
Capital Variation Of Rights Attached To Shares
Category:Capital
Date:08-09-2021
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:20-05-2021
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:14-01-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:06-01-2021
Capital Allotment Shares
Category:Capital
Date:27-05-2020
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:08-01-2020
Accounts With Accounts Type Dormant
Category:Accounts
Date:22-10-2019
Appoint Person Director Company With Name Date
Category:Officers
Date:03-07-2019
Confirmation Statement With Updates
Category:Confirmation Statement
Date:06-01-2019
Incorporation Company
Category:Incorporation
Date:29-01-2018
Innovate Grants
2
This company received a grant of £174920.0 for An Automated Optical Device That Uses Direct Visualisation Of Single Molecules For Routine Screening Of Cancer Biomarkers.. The project started on 01/12/2022 and ended on 31/10/2024.
This company received a grant of £1355256.6 for A Novel Automated Optical Device That Rapidly Screens Large Numbers Of Patient Samples For Past And Present Covid-19 Infection. The project started on 01/08/2021 and ended on 31/03/2023.